Is BMN 673 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use BMN 673? Is BMN 673 safe for nursing mother and child? Does BMN 673 extracts into breast milk? Does BMN 673 has any long term or short term side effects on infants? Can BMN 673 influence milk supply or can BMN 673 decrease milk supply in lactating mothers?
Answer by DrLact: About BMN 673 usage in lactation
No information is available on the clinical use of BMN 673 during breastfeeding. Because BMN 673 is 74% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during BMN 673 therapy and for one month after the last dose.
Alternate Drugs
Cisplatin(Unsafe)
Nivolumab(Unsafe)
Imatinib(Unsafe)
Cetuximab(Unsafe)
Busulfan(Dangerous)
Vinblastine(Dangerous)
Gemcitabine(Dangerous)
Carboplatin(Dangerous)
Letrozole(Dangerous)
Bleomycin(Dangerous)
Azelaic Acid(Safe)
Paclitaxel(Dangerous)
Dactinomycin(Dangerous)
Exemestane(Dangerous)
Vinorelbine(Dangerous)
Cladribine(Dangerous)
Fluorouracil(Dangerous)
Dacarbazine(Dangerous)
Alemtuzumab(Low Risk)
Erlotinib(Unsafe)
Rituximab(Low Risk)
Vincristine(Dangerous)
Dasatinib(Unsafe)
Bevacizumab(Low Risk)
Thioguanine(Dangerous)
Tamoxifen(Dangerous)
Docetaxel(Dangerous)
Mitoxantrone(Dangerous)
Pazopanib(Unsafe)
Mercaptopurine(Safe)
Nilotinib(Unsafe)
Hydroxyurea(Low Risk)
Etoposide(Dangerous)
Trastuzumab(Unsafe)
Doxorubicin(Dangerous)
Ipilimumab(Unsafe)
Cyclophosphamide(Dangerous)
Gemcitabine(Dangerous)
Erlotinib(Unsafe)
Allopurinol(Safe)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Erlotinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)